Renaissance Capital logo

GoodRx Holdings Priced, Nasdaq: GDRX

Operates a prescription drug price comparison platform.

Industry: Health Care

Latest Trade: $52.04 0.00 (0.0%)

First Day Return: +53.0%

Return from IPO: +57.7%

Industry: Health Care

GoodRx was founded to solve the challenges that consumers face in understanding, accessing, and affording healthcare. We started with a price comparison tool for prescriptions, offering consumers free access to lower prices on their medication. We wanted to help ensure that no parent had to choose between their child’s next meal and their life-saving medication. Today, we believe our expanded platform improves the health and financial well-being of American families by providing easy access to price transparency and affordability solutions for generic and brand medications, affordable and convenient medical provider consultations via telehealth and additional healthcare services and information. Based on our research, from inception through June 30, 2020, we estimate that approximately 18 million of our consumers could not have afforded to fill their prescriptions without the savings provided by GoodRx. Furthermore, a July 2020 survey we commissioned from Lab42 Research LLC found that 68% of healthcare providers surveyed have recommended GoodRx to patients. In addition to reducing the costs of healthcare for consumers, we believe that our offerings can help drive greater medication adherence, faster treatment and better patient outcomes.
more less
IPO News for GoodRx Holdings
more
IPO Data
IPO File Date 08/28/2020
Offer Price $33.00
Price Range $24.00 - $28.00
Offer Shares (mm) 34.6
Deal Size ($mm) $1,142
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/22/2020
Offer Price $33.00
Price Range $24.00 - $28.00
Offer Shares (mm) 34.6
Deal Size ($mm) $1,142
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Santa Monica, CA
Founded 2011
Employees 338
Website www.goodrx.com